SEC
|
Forte Steve
|
EVP, CHIEF FINANCIAL OFFICER
|
|
-6.9K
|
$1.14
|
-$7.85K
|
|
SEC
|
Koehler Maria
|
EVP, CHIEF MEDICAL OFFICER
|
|
-3.6K
|
$1.14
|
-$4.10K
|
|
SEC
|
Segal Lloyd Mitchell
|
PRESIDENT AND CEO
|
|
-21K
|
$1.14
|
-$24.14K
|
|
SEC
|
Zinda Michael
|
EVP, CHIEF SCIENTIFIC OFFICER
|
|
-5.6K
|
$1.14
|
-$6.40K
|
|
SEC
|
Forte Steve
|
EVP, CHIEF FINANCIAL OFFICER
|
|
-1.6K
|
$4.62
|
-$7.46K
|
|
SEC
|
Koehler Maria
|
EVP, CHIEF MEDICAL OFFICER
|
|
-800
|
$4.65
|
-$3.72K
|
|
SEC
|
Segal Lloyd Mitchell
|
PRESIDENT AND CEO
|
|
-5.1K
|
$4.62
|
-$23.75K
|
|
SEC
|
Zinda Michael
|
EVP, CHIEF SCIENTIFIC OFFICER
|
|
-860
|
$4.65
|
-$4.00K
|
|
SEC
|
Forte Steve
|
EVP, CHIEF FINANCIAL OFFICER
|
|
-2.5K
|
$4.67
|
-$11.56K
|
|
SEC
|
Koehler Maria
|
EVP, CHIEF MEDICAL OFFICER
|
|
-1.5K
|
$4.67
|
-$7.01K
|
|
SEC
|
Segal Lloyd Mitchell
|
PRESIDENT AND CEO
|
|
-8K
|
$4.69
|
-$37.29K
|
|
SEC
|
Zinda Michael
|
EVP, CHIEF SCIENTIFIC OFFICER
|
|
-1.4K
|
$4.67
|
-$6.30K
|
|
SEC
|
Zinda Michael
|
EVP, Chief Scientific Officer
|
|
-3.5K
|
$12.03
|
-$42.53K
|
|
SEC
|
Zinda Michael
|
EVP, Chief Scientific Officer
|
|
-1.2K
|
$12.04
|
-$14.45K
|
|
SEC
|
Koehler Maria
|
EVP, Chief Medical Officer
|
|
+49K
|
$2.06
|
+$99.92K
|
|
SEC
|
Jerel Davis
|
N/A
|
|
-250K
|
$16.00
|
-$4.00M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+149K
|
$12.73
|
+$1.90M
|
|
SEC
|
Jerel Davis
|
N/A
|
|
-1.4M
|
$5.22
|
-$7.47M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+1.8M
|
$11.90
|
+$21.86M
|
|
SEC
|
Versant Vantage I GP-GP, LLC
|
N/A
|
|
-1.5M
|
$5.24
|
-$7.60M
|
|
SEC
|
Versant Ventures V (Canada), L.P.
|
N/A
|
|
-1.5M
|
$5.24
|
-$7.60M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+420K
|
$8.50
|
+$3.57M
|
|
SEC
|
Zinda Michael
|
EVP, Chief Science Officer
|
|
-533
|
$11.30
|
-$6.02K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+998K
|
$14.10
|
+$14.07M
|
|
SEC
|
Koehler Maria
|
EVP, Chief Medical Officer
|
|
+49K
|
$2.06
|
+$99.93K
|
|
SEC
|
Zinda Michael
|
EVP, Chief Science Officer
|
|
+46K
|
$2.00
|
+$92.08K
|
|
SEC
|
Civik Thomas
|
N/A
|
|
+7.5K
|
$28.08
|
+$210.60K
|
|
SEC
|
Zinda Michael
|
EVP, Chief Science Officer
|
|
-20K
|
$27.33
|
-$546.60K
|
|
SEC
|
Bonita David P
|
N/A
|
|
-8.1K
|
$33.99
|
-$274.78K
|
|
SEC
|
ORBIMED CAPITAL LLC
|
N/A
|
|
-8.1K
|
$33.99
|
-$274.78K
|
|
SEC
|
Bonita David P
|
N/A
|
|
-38K
|
$34.08
|
-$1.29M
|
|
SEC
|
ORBIMED CAPITAL LLC
|
N/A
|
|
-38K
|
$34.08
|
-$1.29M
|
|
SEC
|
Bonita David P
|
N/A
|
|
-18K
|
$34.07
|
-$615.75K
|
|
SEC
|
ORBIMED CAPITAL LLC
|
N/A
|
|
-18K
|
$34.07
|
-$615.75K
|
|
SEC
|
Bonita David P
|
N/A
|
|
-18K
|
$34.17
|
-$622.41K
|
|
SEC
|
ORBIMED CAPITAL LLC
|
N/A
|
|
-18K
|
$34.17
|
-$622.41K
|
|
SEC
|
Bonita David P
|
N/A
|
|
-41K
|
$34.10
|
-$1.39M
|
|
SEC
|
ORBIMED CAPITAL LLC
|
N/A
|
|
-20K
|
$34.10
|
-$693.18K
|
|
SEC
|
Zinda Michael
|
EVP, Chief Science Officer
|
|
-15K
|
$33.99
|
-$509.85K
|
|
SEC
|
Foley Todd
|
N/A
|
|
-27K
|
$33.55
|
-$917.63K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-62K
|
$33.55
|
-$2.08M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-8.5K
|
$34.06
|
-$288.15K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-19K
|
$34.06
|
-$653.95K
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
-1.5K
|
$35.61
|
-$54.91K
|
|
SEC
|
Foley Todd
|
N/A
|
|
-13K
|
$33.51
|
-$423.57K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-29K
|
$33.51
|
-$961.33K
|
|
SEC
|
Foley Todd
|
N/A
|
|
-19K
|
$34.36
|
-$648.00K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-43K
|
$34.36
|
-$1.47M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-18K
|
$33.77
|
-$617.79K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-42K
|
$33.77
|
-$1.40M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-2.7K
|
$33.25
|
-$91.20K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-6.2K
|
$33.25
|
-$207.05K
|
|
SEC
|
Foley Todd
|
N/A
|
|
-27K
|
$34.05
|
-$921.63K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-61K
|
$34.05
|
-$2.09M
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
-1.6K
|
$35.00
|
-$55.16K
|
|
SEC
|
Foley Todd
|
N/A
|
|
-26K
|
$32.01
|
-$820.16K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-58K
|
$32.01
|
-$1.86M
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
-36K
|
$27.90
|
-$1.00M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-17K
|
$32.47
|
-$545.04K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-38K
|
$32.47
|
-$1.24M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-17K
|
$32.82
|
-$557.58K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-39K
|
$32.82
|
-$1.27M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-143K
|
$34.75
|
-$4.97M
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-325K
|
$34.75
|
-$11.29M
|
|
SEC
|
Foley Todd
|
N/A
|
|
-43K
|
$16.71
|
-$710.19K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-69K
|
$23.45
|
-$1.61M
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
-3.8K
|
$35.03
|
-$132.06K
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
-5.6K
|
$35.04
|
-$196.22K
|
|
SEC
|
Zinda Michael
|
EVP, Chief Science Officer
|
|
-15K
|
$32.71
|
-$490.65K
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
-5.5K
|
$35.01
|
-$192.98K
|
|
SEC
|
Foley Todd
|
N/A
|
|
-401K
|
$28.18
|
-$11.29M
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
-671K
|
$28.18
|
-$18.90M
|
|
SEC
|
Zinda Michael
|
EVP, Chief Science Officer
|
|
-35K
|
$33.87
|
-$1.18M
|
|
SEC
|
Bonita David P
|
N/A
|
|
+3.4M
|
$20.00
|
+$67.51M
|
|
SEC
|
EVNIN LUKE
|
N/A
|
|
+3M
|
$20.00
|
+$60.08M
|
|
SEC
|
Foley Todd
|
N/A
|
|
+3M
|
$20.00
|
+$60.08M
|
|
SEC
|
Forte Steve
|
EVP, Chief Financial Officer
|
|
+5K
|
$20.00
|
+$100.00K
|
|
SEC
|
GADICKE ANSBERT
|
N/A
|
|
+5.4M
|
$20.00
|
+$107.84M
|
|
SEC
|
Jerel Davis
|
N/A
|
|
+6.5M
|
$20.00
|
+$129.91M
|
|
SEC
|
Morrison Briggs
|
N/A
|
|
+4.8K
|
$20.00
|
+$96.00K
|
|
SEC
|
ORBIMED CAPITAL LLC
|
N/A
|
|
+3.4M
|
$20.00
|
+$67.51M
|
|
SEC
|
RHOADS ANN D
|
N/A
|
|
+4K
|
$20.00
|
+$80.00K
|
|
SEC
|
SCHAFER CAROL
|
N/A
|
|
+8K
|
$20.00
|
+$160.00K
|
|
SEC
|
Segal Lloyd Mitchell
|
President and CEO
|
|
+5K
|
$20.00
|
+$100.00K
|
|
SEC
|
Versant Vantage I GP-GP, LLC
|
N/A
|
|
+6.5M
|
$20.00
|
+$129.91M
|
|
SEC
|
Versant Ventures V (Canada), L.P.
|
N/A
|
|
+6.5M
|
$20.00
|
+$129.91M
|
|